Psychiatric Times articleshttps://www.psychiatrictimes.com/newsPsychiatric Times articles© 2026 MJH Life Sciences™ and Psychiatric Times. All rights reserved.Thu, 17 Sep 2026 17:13:24 +00005en-us14447https://www.psychiatrictimes.com/newshttps://www.psychiatrictimes.com/logo.webphttps://www.psychiatrictimes.com/view/the-silence-between-the-questions-reflections-on-adolescent-suicide-risk-when-intent-is-unclearhttps://www.psychiatrictimes.com/view/the-silence-between-the-questions-reflections-on-adolescent-suicide-risk-when-intent-is-unclear<![CDATA[In this case exploration, a teen survives a gun injury yet denies self-harm, pushing clinicians to read beyond words and plan safety when suicide intent is unclear.]]>Thu, 17 Sep 2026 16:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/embodied-technologies-for-mental-health-leveraging-synthetic-emotions-for-dissociation-and-anhedoniahttps://www.psychiatrictimes.com/view/embodied-technologies-for-mental-health-leveraging-synthetic-emotions-for-dissociation-and-anhedonia<![CDATA[How tuning body signals with closed-loop sound and chill tech may ease dissociation and anhedonia, offering drug-free add-ons to therapy.]]>Thu, 17 Sep 2026 14:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/treating-cannabis-use-disorder-withdrawal-with-pp-01-nida-grant-accelerates-phase-3-trialhttps://www.psychiatrictimes.com/view/treating-cannabis-use-disorder-withdrawal-with-pp-01-nida-grant-accelerates-phase-3-trial<![CDATA[A fast-tracked once-daily pill aims to ease cannabis withdrawal by restoring CB1 signaling and reward-pathway balance as phase 3 enrollment surges.]]>Thu, 17 Sep 2026 13:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/questioning-the-status-quo-in-psychiatric-emergency-carehttps://www.psychiatrictimes.com/view/questioning-the-status-quo-in-psychiatric-emergency-care<![CDATA[How EmPATH units replace psychiatric ED boarding with rapid, trauma-informed treatment—cutting stays and admissions while improving follow‑up.]]>Wed, 16 Sep 2026 17:50:51 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/new-adult-adhd-guidelines-what-resources-are-coming-soonhttps://www.psychiatrictimes.com/view/new-adult-adhd-guidelines-what-resources-are-coming-soon<![CDATA[APSARD nears publishing adult ADHD guidelines. Here's what resources you can expect to see upon their publication. ]]>Wed, 16 Sep 2026 16:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/podcast-griefs-impact-on-public-health-and-policy-with-joyal-mulheron-msc-and-lauren-rowley-mba-rnhttps://www.psychiatrictimes.com/view/podcast-griefs-impact-on-public-health-and-policy-with-joyal-mulheron-msc-and-lauren-rowley-mba-rn<![CDATA[Two grief experts expose the hidden health, social, and economic toll of bereavement—and the policy gaps leaving millions of grieving Americans unsupported.]]>Wed, 16 Sep 2026 15:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/lessons-from-psychedelics-on-receptor-binding-and-subsequent-functional-activityhttps://www.psychiatrictimes.com/view/lessons-from-psychedelics-on-receptor-binding-and-subsequent-functional-activity<![CDATA[Learn how the inhibition constant and 5-HT2A binding explain LSD effects—and why potent atypical antipsychotics may rapidly end a bad trip.]]>Wed, 16 Sep 2026 14:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/fda-hearing-on-psychedelic-medicine-reveals-a-field-divided-on-the-road-to-approvalhttps://www.psychiatrictimes.com/view/fda-hearing-on-psychedelic-medicine-reveals-a-field-divided-on-the-road-to-approval<![CDATA[FDA hearing spotlights debates over psychedelic therapy: who administers, how to prove efficacy, and how to track safety as approvals near.]]>Tue, 15 Sep 2026 20:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/insights-on-the-new-adult-adhd-guidelines-a-conversation-with-the-president-of-apsardhttps://www.psychiatrictimes.com/view/insights-on-the-new-adult-adhd-guidelines-a-conversation-with-the-president-of-apsard<![CDATA[New US adult ADHD guidance nears publication, promising clearer diagnosis, comorbidity screening, and clinician training to curb misdiagnosis.]]>Tue, 15 Sep 2026 16:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/reframing-binge-eating-disorder-through-circuit-level-neurosciencehttps://www.psychiatrictimes.com/view/reframing-binge-eating-disorder-through-circuit-level-neuroscience<![CDATA[New research maps an mPFC–zona incerta circuit that drives punishment-resistant binge eating and hints at personalized brain stimulation targets for better treatment.]]>Tue, 15 Sep 2026 15:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/initiation-of-bloom-phase-3-study-of-lpcn-1154-for-postpartum-depressionhttps://www.psychiatrictimes.com/view/initiation-of-bloom-phase-3-study-of-lpcn-1154-for-postpartum-depression<![CDATA[Phase 3 BLOOM tests 48-hour at-home oral brexanolone for rapid postpartum depression relief, with tighter monitoring after prior trial issues.]]>Tue, 15 Sep 2026 14:06:20 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/back-to-school-supporting-young-patients-in-their-learning-journeyshttps://www.psychiatrictimes.com/view/back-to-school-supporting-young-patients-in-their-learning-journeys<![CDATA[FDA clears Simtriyo, first NDSRI stimulant for ADHD ages 6 and older, as millions return to school—see what this means for treatment.]]>Tue, 15 Sep 2026 14:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/phase-2-failure-jnj-5120-pipe-307-for-the-treatment-of-major-depressive-disorderhttps://www.psychiatrictimes.com/view/phase-2-failure-jnj-5120-pipe-307-for-the-treatment-of-major-depressive-disorder<![CDATA[Phase 2 MOONLIGHT-1 shows JNJ-5120/PIPE-307 misses day‑5 MADRS improvement in MDD, yet remains well tolerated as J&amp;J reviews next steps.]]>Tue, 15 Sep 2026 13:28:22 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/apsard-president-brooke-molina-phd-on-the-case-for-adult-adhd-guidelineshttps://www.psychiatrictimes.com/view/apsard-president-brooke-molina-phd-on-the-case-for-adult-adhd-guidelines<![CDATA[APSARD's US Adult ADHD Guidelines have advanced to Stage 3, the last review phase before a targeted fall 2026 publication.]]>Tue, 15 Sep 2026 13:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/a-schizophrenia-case-study-persistent-symptoms-beyond-hospitalizationhttps://www.psychiatrictimes.com/view/a-schizophrenia-case-study-persistent-symptoms-beyond-hospitalization<![CDATA[A detailed case study reveals how positive, negative, and cognitive symptoms can persist for years even when a patient appears clinically stable, challenging the panel to define what genuine functional recovery should look like.]]>Tue, 15 Sep 2026 12:05:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/why-schizophrenia-treatment-falls-short-stigma-fear-and-delayed-carehttps://www.psychiatrictimes.com/view/why-schizophrenia-treatment-falls-short-stigma-fear-and-delayed-care<![CDATA[Despite effective treatments, most patients with schizophrenia go undertreated. The panel examines how stigma, fear, and outdated expectations for recovery continue to limit both patients and the clinicians who treat them.]]>Tue, 15 Sep 2026 12:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/morning-rounds-september-7-14https://www.psychiatrictimes.com/view/morning-rounds-september-7-14<![CDATA[Catch up on last week's news in psychiatry. ]]>Mon, 14 Sep 2026 17:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/vol-43-issue-9-interactivehttps://www.psychiatrictimes.com/view/vol-43-issue-9-interactive<![CDATA[Interactive Issue]]>Mon, 14 Sep 2026 14:48:04 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/debunking-the-top-10-misleading-claims-about-antidepressantshttps://www.psychiatrictimes.com/view/debunking-the-top-10-misleading-claims-about-antidepressants<![CDATA[Experts dissect 10 common antidepressant myths, separating evidence from fear on efficacy, addiction, suicide risk, withdrawal, and safe tapering.]]>Mon, 14 Sep 2026 14:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/positive-topline-results-from-phase-3-panorama-study-of-dt120-odt-in-generalized-anxiety-disorderhttps://www.psychiatrictimes.com/view/positive-topline-results-from-phase-3-panorama-study-of-dt120-odt-in-generalized-anxiety-disorder<![CDATA[Single-dose DT120 ODT delivers rapid, sustained anxiety relief in phase 3 GAD trial, supporting FDA breakthrough path and NDA plans.]]>Mon, 14 Sep 2026 13:34:01 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/get-ready-for-the-psych-consult-second-opinion-a-new-video-podcast-serieshttps://www.psychiatrictimes.com/view/get-ready-for-the-psych-consult-second-opinion-a-new-video-podcast-series<![CDATA[Explore how hormones, labs, and medical conditions reshape psychiatric care—practical ordering tips and red flags from a new clinician-focused podcast.]]>Mon, 14 Sep 2026 13:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/state-funding-for-suicide-prevention-and-crisis-services-climbs-sharply-from-2021-to-2026https://www.psychiatrictimes.com/view/state-funding-for-suicide-prevention-and-crisis-services-climbs-sharply-from-2021-to-2026<![CDATA[Per capita state suicide prevention funding rose 6-fold from 2021 to 2025 and was more than double in states with 988 telecom fees, study finds. ]]>Fri, 11 Sep 2026 15:05:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/how-can-psychiatrists-help-patients-build-resilience-after-traumahttps://www.psychiatrictimes.com/view/how-can-psychiatrists-help-patients-build-resilience-after-trauma<![CDATA[Psychiatrist Craig Katz, MD, shows how resilience-based trauma care reduces stigma, avoids PTSD overdiagnosis, and guides patients.]]>Fri, 11 Sep 2026 15:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/rethinking-occupational-health-for-emergency-responders-in-psychiatryhttps://www.psychiatrictimes.com/view/rethinking-occupational-health-for-emergency-responders-in-psychiatry<![CDATA[New patients with cognitive complaints could need trauma screening; CBT shows promise after acute stress.]]>Fri, 11 Sep 2026 14:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/non-pharmacologic-strategies-and-the-dice-approach-to-agitationhttps://www.psychiatrictimes.com/view/non-pharmacologic-strategies-and-the-dice-approach-to-agitation<![CDATA[Before any prescription is written, non-pharmacologic strategies and a structured framework guide the panel's approach to agitation, alongside a biological explanation for why redirection so often fails.]]>Fri, 11 Sep 2026 12:05:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/building-a-thorough-adult-adhd-diagnosishttps://www.psychiatrictimes.com/view/building-a-thorough-adult-adhd-diagnosis<![CDATA[Diagnosing adult ADHD demands more than a single office visit. The panel outlines the history-taking, collateral information, and follow-up structure needed to reach a confident, accurate diagnosis.]]>Fri, 11 Sep 2026 12:05:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/disaster-psychiatry-lessons-from-9-11-and-covid-19https://www.psychiatrictimes.com/view/disaster-psychiatry-lessons-from-9-11-and-covid-19<![CDATA[How disaster psychiatry shifts from forced debriefs to proactive outreach, from Ground Zero to COVID wards—building trauma-ready community care.]]>Fri, 11 Sep 2026 12:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/adult-adhd-prevalence-and-the-diversity-of-symptomshttps://www.psychiatrictimes.com/view/adult-adhd-prevalence-and-the-diversity-of-symptoms<![CDATA[Adult ADHD is more common than clinicians assume, and its symptoms look different from the classic childhood presentation. The panel opens by reframing prevalence and heterogeneity as the foundation for accurate diagnosis.]]>Fri, 11 Sep 2026 12:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/coordinating-care-and-caregiver-burden-in-agitationhttps://www.psychiatrictimes.com/view/coordinating-care-and-caregiver-burden-in-agitation<![CDATA[Agitation does not stay contained to the patient. The panel examines the data linking agitation to caregiver burden, and the communication gaps that complicate coordinating care across specialties.]]>Fri, 11 Sep 2026 12:00:00 GMTPsychiatric TimesusPsychiatric Times Articleshttps://www.psychiatrictimes.com/view/new-phase-2-clinical-trial-initiating-in-2027-evaluating-psilocybin-assisted-therapy-for-major-depressive-disorderhttps://www.psychiatrictimes.com/view/new-phase-2-clinical-trial-initiating-in-2027-evaluating-psilocybin-assisted-therapy-for-major-depressive-disorder<![CDATA[Health Canada has authorized a 200-participant phase 2 trial testing a single psilocybin dose for major depressive disorder, with dosing set to begin in 2027. ]]>Thu, 10 Sep 2026 18:20:29 GMTPsychiatric TimesusPsychiatric Times Articles